Capital Analysts LLC’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-250
| Closed | -$19K | – | 1036 |
|
|
2023
Q1 | $19K | Buy |
+250
| New | +$19K | ﹤0.01% | 744 |
|
|
2021
Q2 | – | Sell |
-20
| Closed | -$3K | – | 1096 |
|
|
2021
Q1 | $3K | Buy |
+20
| New | +$3K | ﹤0.01% | 940 |
|
|
2020
Q3 | – | Sell |
-1,500
| Closed | -$168K | – | 768 |
|
|
2020
Q2 | $168K | Hold |
1,500
| – | – | 0.02% | 229 |
|
|
2020
Q1 | $116K | Sell |
1,500
-2,375
| -61% | -$184K | 0.01% | 243 |
|
|
2019
Q4 | $369K | Sell |
3,875
-4,150
| -52% | -$395K | 0.04% | 198 |
|
|
2019
Q3 | $611K | Buy |
8,025
+625
| +8% | +$47.6K | 0.06% | 177 |
|
|
2019
Q2 | $649K | Buy |
7,400
+750
| +11% | +$65.8K | 0.07% | 174 |
|
|
2019
Q1 | $602K | Buy |
6,650
+1,650
| +33% | +$149K | 0.07% | 168 |
|
|
2018
Q4 | $359K | Buy |
+5,000
| New | +$359K | 0.05% | 173 |
|